Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Drug Advertising, E-Commerce Working Groups To Be Formed By 2000

Executive Summary

The European Commission's Pharmaceutical Committee plans to establish ad hoc working groups on advertising and electronic commerce by late 1999 or early 2000.

You may also be interested in...



EMEA/Eastern Block To Form Drug Regulation Action Plan In February

EU regulators and their counterparts from Central and Eastern European countries will meet in Budapest in early February to form an action plan for the European Commission's Pan-European Regulatory Forum (PERF) for pharmaceuticals.

P&U "Dear Doctor" Letter Notes New Label Warning For Sleep Onset

Pharmacia & Upjohn plans to conduct studies of Mirapex (pramipexole) in response to an increasing number of reports of sudden sleep onset during daily activities, the company said.

Pharmacia & Upjohn Discussing Mirapex Sudden Sleep Onset With FDA

FDA and Pharmacia & Upjohn are discussing possible labeling changes to the Parkinson's therapy Mirapex (pramipexole) to reflect reports of sudden sleep onset in patients.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS035040

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel